Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michèle Calas

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Proceedings of the National Academy of Sciences of the United States of America|October 20, 2004
Prodrugs of bisthiazolium salts are orally potent antimalarialsHenri J Vial, Sharon Wein, Christine Farenc, et al.
Journal of Medicinal Chemistry|May 13, 2005
Mono- and bis-thiazolium salts have potent antimalarial activityAbdallah Hamzé, Eric Rubi, Pascal Arnal, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2006
Potent antihematozoan activity of novel bisthiazolium drug T16: evidence for inhibition of phosphatidylcholine metabolism in erythrocytes infected with Babesia and Plasmodium sppEric Richier, Giancarlo A Biagini, Sharon Wein, et al.
Journal of Medicinal Chemistry|May 18, 2012
Disulfide prodrugs of albitiazolium (T3/SAR97276): synthesis and biological activitiesSergio A Caldarelli, Matthieu Hamel, Jean-Frédéric Duckert, et al.
Bioorganic & Medicinal Chemistry Letters|July 8, 2010
Exploration of potential prodrug approach of the bis-thiazolium salts T3 and T4 for orally delivered antimalarialsSergio A Caldarelli, Michel Boisbrun, Karine Alarcon, et al.
Science (New York, N.Y.)|February 16, 2002
A class of potent antimalarials and their specific accumulation in infected erythrocytesKai Wengelnik, Valerie Vidal, Marie L Ancelin, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Proceedings of the National Academy of Sciences of the United States of America|October 20, 2004
Prodrugs of bisthiazolium salts are orally potent antimalarialsHenri J Vial, Sharon Wein, Christine Farenc, et al.
Journal of Medicinal Chemistry|May 13, 2005
Mono- and bis-thiazolium salts have potent antimalarial activityAbdallah Hamzé, Eric Rubi, Pascal Arnal, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2006
Potent antihematozoan activity of novel bisthiazolium drug T16: evidence for inhibition of phosphatidylcholine metabolism in erythrocytes infected with Babesia and Plasmodium sppEric Richier, Giancarlo A Biagini, Sharon Wein, et al.
Journal of Medicinal Chemistry|May 18, 2012
Disulfide prodrugs of albitiazolium (T3/SAR97276): synthesis and biological activitiesSergio A Caldarelli, Matthieu Hamel, Jean-Frédéric Duckert, et al.
Bioorganic & Medicinal Chemistry Letters|July 8, 2010
Exploration of potential prodrug approach of the bis-thiazolium salts T3 and T4 for orally delivered antimalarialsSergio A Caldarelli, Michel Boisbrun, Karine Alarcon, et al.
Science (New York, N.Y.)|February 16, 2002
A class of potent antimalarials and their specific accumulation in infected erythrocytesKai Wengelnik, Valerie Vidal, Marie L Ancelin, et al.
Pageof 2